Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cell Discovery|April 4, 2023
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variantsXiangyang Chi, Lingyun Xia, Guanying Zhang, et al.International Immunopharmacology|December 28, 2020
Tetanus vaccine-induced human neutralizing antibodies provide full protection against neurotoxin challenge in miceGuanying Zhang, Rui Yu, Xiangyang Chi, et al.Virology Journal|August 12, 2025
Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cellsJie Li, Shaoyan Wang, Yue Cui, et al.Signal Transduction and Targeted Therapy|July 29, 2022
Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCsBusen Wang, Jinghan Xu, Shipo Wu, et al.Virologica Sinica|December 6, 2025
Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodiesKewen Qian, Yu Zhang, Zhihao Li, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2025
Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion GlycoproteinYi Ren, Pengfei Fan, Xinghai Zhang, et al.Science (New York, N.Y.)|June 24, 2020
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2Xiangyang Chi, Renhong Yan, Jun Zhang, et al.Nature Communications|May 21, 2024
A potent Henipavirus cross-neutralizing antibody reveals a dynamic fusion-triggering pattern of the G-tetramerPengfei Fan, Mengmeng Sun, Xinghai Zhang, et al.Signal Transduction and Targeted Therapy|April 28, 2022
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccinationXiangyang Chi, Yingying Guo, Guanying Zhang, et al.Nature Communications|March 18, 2026
Multimodal imaging reveals a lysosomal drug reservoir that drives heterogeneous distribution of PARP inhibitorsCarmen R Moncayo, Restuadi Restuadi, Guanying Zhang, et al.Pageof 4